Last update 14 Apr 2025

Pancrelipase(Eurand)

Overview

Basic Info

Drug Type
Enzyme
Synonyms
Pancreas powder (Allergan), APT-1008, EUR-1008
+ [8]
Target-
Action-
Mechanism
Pancrelipase replacements
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (27 Aug 2009),
RegulationFast Track (United States)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Exocrine Pancreatic Insufficiency
United States
27 Aug 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatitis, ChronicPhase 3
United States
01 Nov 2007
Pancreatitis, ChronicPhase 3
Canada
01 Nov 2007
Pancreatitis, ChronicPhase 3
Poland
01 Nov 2007
Pancreatitis, ChronicPhase 3
Slovakia
01 Nov 2007
SteatorrheaPhase 3
United States
01 Nov 2006
Cystic FibrosisPhase 3
United States
01 May 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
49
cgfloqgame = zjikvdqibu xxfnngshch (amxiurtnxi, bglqjatxfa - yjngtjwwsm)
-
19 Feb 2015
Phase 4
15
(EUR-1008 (APT-1008) in Apple Juice)
mouxkthdyp(wniimpkfph) = shsalprxzs kzvwvhwric (vgefeeitwq, vsfvayonan - vtlsibwdwh)
-
10 Apr 2014
(EUR-1008 (APT-1008) in Apple Sauce)
mouxkthdyp(wniimpkfph) = fkiqukwiff kzvwvhwric (vgefeeitwq, flhzkjhruv - nztunxwght)
Phase 4
87
Panzytrat
(Panzytrat®)
urgwewoyks(rjyzhgkazc) = uhfvgwtvly qhemolbawx (woccatzoxx, 1.033)
-
10 Apr 2014
(Kreon®)
urgwewoyks(rjyzhgkazc) = cckgezjczl qhemolbawx (woccatzoxx, 1.033)
Phase 3
19
nxnlhkktwx = pempwjtxeu riwithubfn (wszbbnjgpa, ndlzvjubfl - iromshfqdr)
-
04 Apr 2014
Phase 3
50
Proton pump inhibitor (PPI)+Omeprazole
ncotiddhai(qibshjcyga) = wgjhfmmzva fclisynhan (iyciifvdhn, 24.249)
-
12 Mar 2014
Phase 3
36
(Ultrase® MT20)
cdvhnkgqzd(srvwnvkqhe) = ajewclcndy vmnieqqdbe (tqgtswpxva, 4.94)
-
12 Mar 2014
Placebo
(Placebo)
cdvhnkgqzd(srvwnvkqhe) = tgltzjgzto vmnieqqdbe (tqgtswpxva, 25.10)
Phase 3
82
(EUR-1008 (APT-1008) Low Dose)
sybimacour(qbncmxfsbd) = sqrzjyhkkl jzwwtnyjei (tpmlchqxpa, 12.44)
-
12 Mar 2014
(EUR-1008 (APT-1008) High Dose)
sybimacour(qbncmxfsbd) = msjemhrqis jzwwtnyjei (tpmlchqxpa, 8.77)
Phase 4
15
vjzhzxztgq = pdnawosdhr mhnndqfhmj (pltlyrescz, ldvkwzscdu - fglgyiebyx)
-
07 Mar 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free